El-Shoukrofy, M. S., Atta, A., Fahmy, S., Sriram, D., Shehat, M. G., Labouta, I. M., & Mahran, M. A. Challenging the Biginelli scaffold to surpass the first line antitubercular drugs: Mycobacterium tuberculosis thymidine monophosphate kinase (TMPKmt) inhibition activity and molecular modelling studies. Taylor & Francis Group.
Chicago Style (17th ed.) CitationEl-Shoukrofy, Mai S., Amal Atta, Salwa Fahmy, Dharmarajan Sriram, Michael G. Shehat, Ibrahim M. Labouta, and Mona A. Mahran. Challenging the Biginelli Scaffold to Surpass the First Line Antitubercular Drugs: Mycobacterium Tuberculosis Thymidine Monophosphate Kinase (TMPKmt) Inhibition Activity and Molecular Modelling Studies. Taylor & Francis Group.
MLA (9th ed.) CitationEl-Shoukrofy, Mai S., et al. Challenging the Biginelli Scaffold to Surpass the First Line Antitubercular Drugs: Mycobacterium Tuberculosis Thymidine Monophosphate Kinase (TMPKmt) Inhibition Activity and Molecular Modelling Studies. Taylor & Francis Group.